.Basilea Pharmaceutica's job developing new antifungals has gotten a significant improvement coming ...
.Having already scooped up the U.S. civil liberties to Capricor Therapies' late-stage Duchenne muscl...
.After dismissing the decision date for Applied Therapeutics' metabolic problem drug govorestat, the...
.Novo Nordisk is continuing its own press in to genetic medications, agreeing to compensate NanoVati...
.Innovent Biologics has produced the scenario that its own checkpoint inhibitor-cytokine combination...
.A period 3 test of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate...
.Five months after Rakovina Therapies turned toward artificial intelligence, the cancer-focused biot...
.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, reporting phase 3...
.Though Alkeus Pharmaceuticals' oral eye illness asset failed to significantly minimize geographical...
.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually simple to overlook a sm...
.Immune system checkpoint inhibitors are actually the superheroes of cancer cells therapy. Medicatio...
.Invite to today's Chutes & Ladders, our summary of substantial management hirings, shootings as ...
.Regeneron is actually back along with long-lasting follow-up for its own LAG-3 prevention and PD-1 ...
.AstraZeneca has shared an early consider the functionality of its in-house antibody-drug conjugate ...
.After revealing a phase 3 launch based on good midstage end results, iTeos and also GSK are finally...
.The FDA should be much more open as well as joint to discharge a surge in approvals of unusual cond...
.It's an uncommonly occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Rehabs al...
.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 test, but the biotec...
.Neurocrine Biosciences' schizophrenia course pivot has actually neglected. The biotech was unable t...
.Sanofi has actually brought in an overdue entry to the radioligand event, spending 100 million euro...